Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bio Green Med Solution, Inc. (BGMS)
USD0.90
0.00 (-0.31%)
US NASDAQ Healthcare Medical - Pharmaceuticals
Address
Level 10 592000
Kuala Lumpur, US
Kuala Lumpur, US
CEO
Sing Ee Wong
Website
bgmsglobal.com
IPO
2025-09-12
CIK 1130166 ISIN US23254L8761
Also trades on
NASDAQ Capital Market · CYCC (USD)
NASDAQ Capital Market · CYCCP (USD)
NASDAQ Global Market · BGMS (USD)
NASDAQ Global Market · BGMSP (USD)
Description
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.90
0.00 (-0.31%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
-0.38
Float Shares
2.15M
Free Float %
98.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.14% | +14.48% | -5.14% | -3.30% | -17.69% | -32.70% | -83.46% | -83.46% | -83.46% | -83.46% | -83.46% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.90
DCF (Unlevered)
5.21
+477.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
-83.14
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%+1,637.2% ★
-
EPS growth Medical - Pharmaceuticals: +20.2%+98.7% ★ Q1'26: +57.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-2,341.2% Q1'26: -35.9% (vs Q1'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-1,128.1% Q1'26: -31.6% (vs Q1'25)
-
ROIC Medical - Pharmaceuticals: +6.1%-252.4% Q1'26: -28.8% (vs Q1'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+9,692.4% Q1'26: +531.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
420.0K
est: 263.0K (+59.7%)
|
43.0K
est: 53.0K (-18.9%)
|
747.0K
est: 100.0K (+647.0%)
|
100.0K
100.0K – 100.0K
+0.0% YoY
|
80.58M
80.58M – 80.58M
+80,482.0% YoY
|
118.08M
118.08M – 118.08M
+46.5% YoY
|
| EBITDA |
-25.42M
est: 52.6K (-48,431.7%)
|
-12.00M
est: -10.6K (-113,099.4%)
|
-8.42M
est: -20.0K (-42,012.1%)
|
-20.0K
-20.0K – -20.0K
+0.0% YoY
|
-16.12M
-16.12M – -16.12M
-80,486.0% YoY
|
-23.62M
-23.62M – -23.62M
-46.5% YoY
|
| EBIT |
-25.45M
est: 52.6K (-48,490.7%)
|
-12.00M
est: -10.6K (-113,156.0%)
|
-8.43M
est: -20.0K (-42,037.1%)
|
-20.0K
-20.0K – -20.0K
+0.0% YoY
|
-16.12M
-16.12M – -16.12M
-80,486.0% YoY
|
-23.62M
-23.62M – -23.62M
-46.5% YoY
|
| Net Income |
-22.56M
est: -108.33M (+79.2%)
|
-11.21M
est: -1.02B (+98.9%)
|
-3.00M
est: -618.81M (+99.5%)
|
-587.35M
-587.35M – -587.35M
+5.1% YoY
|
1.92B
1.92B – 1.92B
+427.7% YoY
|
2.88B
2.88B – 2.88B
+49.6% YoY
|
| SGA |
6.72M
est: 7.59M (-11.5%)
|
5.39M
est: 1.63M (+230.9%)
|
7.72M
est: 3.07M (+151.0%)
|
3.07M
3.07M – 3.07M
+0.0% YoY
|
2.48B
2.48B – 2.48B
+80,482.0% YoY
|
3.63B
3.63B – 3.63B
+46.5% YoY
|
| EPS |
-6,420.00
est: -4,854.40 (-32.3%)
|
-501.60
est: -468.00 (-7.2%)
|
-6.45
est: -283.20 (+97.7%)
|
-268.80
-268.80 – -268.80
+5.1% YoY
|
880.80
880.80 – 880.80
+427.7% YoY
|
1,317.60
1,317.60 – 1,317.60
+49.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-3.15M
OE per share TTM
-4.33
Owner's Yield
-72.75%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
260.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.19
Bearish
Ratio by volume
0.64
Neutral
Buys
5
Sells
26
Shares acquired
1.90M
Shares disposed
2.97M
Cash buys
—
Cash sales
17.00
Net activity
-1,066,862
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | Kiu Cu Seng | Director / Officer | A-Award | A | Common Stock | 200,000 | 1.40 | 280.0K | 200,000 | D | ↗ |
| 2025-11-12 | Doris Wong Sing Ee | Director / Officer / 10% Owner | A-Award | A | Common Stock | 300,178 | 1.40 | 420.2K | 1,111,131 | D | ↗ |
| 2025-11-05 | Yap Kim Choy | 10% Owner | J-Other | A | Common Stock | 467,535 | 0.00 | — | 467,535 | D | ↗ |
| 2025-11-05 | Ong Yee Lung | 10% Owner | J-Other | A | Common Stock | 467,535 | 0.00 | — | 467,535 | D | ↗ |
| 2025-11-05 | Kua Khai Loon | 10% Owner | J-Other | A | Common Stock | 467,535 | 0.00 | — | 467,535 | D | ↗ |
| 2025-10-30 | Yap Kim Choy | 10% Owner | S-Sale | D | Common Stock | 112,260 | 1.81 | 202.9K | 28,500 | D | ↗ |
| 2025-10-30 | Ong Yee Lung | 10% Owner | S-Sale | D | Common Stock | 248,814 | 1.80 | 447.9K | 0 | D | ↗ |
| 2025-10-30 | Kua Khai Loon | 10% Owner | S-Sale | D | Common Stock | 242,477 | 1.80 | 436.5K | 0 | D | ↗ |
| 2025-10-29 | Yap Kim Choy | 10% Owner | S-Sale | D | Common Stock | 110,749 | 1.83 | 203.1K | 140,760 | D | ↗ |
| 2025-10-28 | Yap Kim Choy | 10% Owner | S-Sale | D | Common Stock | 13,111 | 1.83 | 24.0K | 251,509 | D | ↗ |
| 2025-10-27 | Yap Kim Choy | 10% Owner | S-Sale | D | Common Stock | 120,250 | 2.12 | 254.7K | 264,620 | D | ↗ |
| 2025-10-24 | Yap Kim Choy | 10% Owner | S-Sale | D | Common Stock | 19,595 | 1.90 | 37.3K | 384,870 | D | ↗ |
| 2025-10-24 | Ong Yee Lung | 10% Owner | S-Sale | D | Common Stock | 19,858 | 1.99 | 39.5K | 248,814 | D | ↗ |
| 2025-10-21 | FITTERS Diversified Berhad | 10% Owner | S-Sale | D | Common Stock | 92,352 | 3.01 | 277.5K | 279,248 | D | ↗ |
| 2025-10-20 | FITTERS Diversified Berhad | 10% Owner | S-Sale | D | Common Stock | 108,107 | 3.09 | 333.8K | 371,600 | D | ↗ |
| 2025-10-16 | Kua Khai Loon | 10% Owner | S-Sale | D | Common Stock | 88,204 | 4.22 | 372.0K | 242,477 | D | ↗ |
| 2025-10-16 | FITTERS Diversified Berhad | 10% Owner | S-Sale | D | Common Stock | 26,051 | 5.50 | 143.3K | 479,707 | D | ↗ |
| 2025-10-15 | Kua Khai Loon | 10% Owner | S-Sale | D | Common Stock | 7,479 | 5.66 | 42.3K | 330,681 | D | ↗ |
| 2025-10-14 | Ong Yee Lung | 10% Owner | S-Sale | D | Common Stock | 135,793 | 6.00 | 814.8K | 268,672 | D | ↗ |
| 2025-10-10 | FITTERS Diversified Berhad | 10% Owner | S-Sale | D | Common Stock | 51,400 | 5.26 | 270.3K | 505,758 | D | ↗ |
| 2025-10-08 | FITTERS Diversified Berhad | 10% Owner | S-Sale | D | Common Stock | 142,000 | 5.29 | 751.6K | 557,158 | D | ↗ |
| 2025-09-16 | Kua Khai Loon | 10% Owner | S-Sale | D | Common Stock | 25,000 | 5.13 | 128.3K | 338,160 | D | ↗ |
| 2025-09-12 | Kua Khai Loon | 10% Owner | S-Sale | D | Common Stock | 22,251 | 6.22 | 138.5K | 363,160 | D | ↗ |
| 2025-09-12 | FITTERS Diversified Berhad | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 699,158 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-7.0K
Shares Outstanding
2.18M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sing Ee Wong | Chairman, Chief Executive Officer & President | 50.5K | — |
| Cu Seng Kiu | Executive Director, Chief Financial Officer & Secretary | 5.1K | male |
| Gill Christie | Director of Human Resources | — | female |
| Grace Kim | Investor Relations Executive | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BGMS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
